Aline
Porto Alegre, Rio Grande do Sul, 90050-170, Brazil
NCT Number: NCT05910216
This is a randomized clinical trial in an online format, which will only include people with PD randomly divided into two groups:
Group 1 - Social Telerehabilitation with Dance and Music Group 2 - Social Telerehabilitation with Multimodal Therapeutic Exercise and Music
Looking for future studies?
Notify Me40 year–90 year
All sexes
Interventional
Not applicable
Porto Alegre, Rio Grande do Sul, 90050-170, Brazil
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This is a social telerehabilitation with dance and music. It will include artistic form, imageries using scenic arts, imageries using aspects of theater and storytelling, movement improvisation, choreography and sequence of movements, complex dance movements, fluidity of movement or connection between one movement and another, rhythmicity and/or movement built with music. It will include instructions for motor learning, music, and socialization
This is a social telerehabilitation with multimodal therapeutic Exercise and Music. It is restricted to the execution of movements within series and standardized and fixed repetitions, with a background music. It will not include dance. It will include instructions for motor learning, music, and socialization.
Time frame: Change from Pre to Post treatment (12 weeks) and FOLLOW-UP (after 4 weeks of study ending)
Quality of life measured by Parkinson's Disease Questionnaire (PDQ-39). Scores range from 0-100 (100 = maximum level of problems).
Time frame: Change from Pre to Post treatment (12 weeks) and FOLLOW-UP (after 4 weeks of study ending)
Well-being measured by the scale Positive and Negative Affect Scale (PANAS). scores range from 10 - 50, a higher score indicates more of a positive affect.
Time frame: Change from Pre to Post treatment (12 weeks) and FOLLOW-UP (after 4 weeks of study ending)
Motor symptoms severity measured by the scale Unified Parkinson's disease rating scale, motor subscale (UPDRS III). Part III: Motor examination: 18 items. Score range: 0-132, 32 and below is mild, 59 and above is severe.
Time frame: Change from Pre to Post treatment (12 weeks)
Functional lower extremity strength measured by the Five times sit to stand test (FTSTS). The time to complete the test is measured, where lower time to perform sit to stand represents better functional lower extremity strength
Time frame: Change from Pre to Post treatment (12 weeks)
Symptoms of Anxiety measured by the Parkinson Anxiety Scale (PAS). Scores range from 0-48 (48= maximum level of problems).
Time frame: Change from Pre to Post treatment (12 weeks)
Executive function by means attention and memory recognition measureb by Online Attention Test (OAT) and Recognition Memory Test (RMT).
Time frame: Change from Pre to Post treatment (12 weeks)
Self-perceptions (feasibility) of technology usability, socialization and benefits of interventions based on a structured interview.
Federal University of Health Science of Porto Alegre
Other
Online Dance Versus Online Therapeutic Exercise on Quality of Life - A Protocol for a Randomized Controlled Trial Investigating Social Telerehabilitation Efficacy in Parkinson's Disease.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06133283
Basal Ganglia Diseases, Brain Diseases
San Antonio, Texas, United States
View Trial DetailsNCT05766813
Basal Ganglia Diseases, Brain Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT07723027
Basal Ganglia Diseases, Brain Diseases
Shakargarh, Punjab Province, Pakistan
View Trial DetailsNCT07361250
Basal Ganglia Diseases, Brain Diseases
Wuhan, Hubei, China
View Trial Details